TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells-Reference-Cited by-同舟云学术

TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells

Published:2015-04-02 Issue:10 Volume:75 Page:1020-1033
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Jain Sumeet¹²,Suklabaidya Sujit¹²,Das Biswajit¹,Raghav Sunil K.¹,Batra Surinder K.³,Senapati Shantibhusan¹

Affiliation:

1. Institute of Life SciencesBhubaneswarOdishaIndia

2. Manipal UniversityManipalKarnatakaIndia

3. Department of Biochemistry and Molecular BiologyBuffett Cancer CenterEppley Institute for Cancer ResearchUniversity of Nebraska Medical CenterOmahaNebraska

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.22983

Reference47 articles.

1. Inflammation in prostate carcinogenesis

2. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate

3. Prostate carcinogenesis and inflammation: emerging insights

4. The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer

5. Prevention and Treatment of Biopsy-Related Complications

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bird’s-Eye View of the Pathophysiologic Role of the Human Urobiota in Health and Disease: Can We Modulate It?;Pathophysiology;2024-02-01

2. Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities;Pharmaceuticals;2024-01-13

3. Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target;Oncogene;2023-12-23

4. Assessing the causal relationship between gut microbiota and prostate cancer: a two-sample Mendelian randomization study;2023-12-23

5. Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic target;2023-06-09